Amendment to: “Investigating Maternal-Fetal Metabolic Interactions in Pregnancies Complicated by Polycystic Ovary Syndrome”
Clinical Scorecard: Investigating Maternal-Fetal Metabolic Interactions in Pregnancies Complicated by Polycystic Ovary Syndrome
At a Glance
Category Detail
Condition Polycystic Ovary Syndrome (PCOS) in pregnancy Key Mechanisms Maternal-fetal metabolic interactions involving multiple metabolites Target Population Pregnant women with PCOS Care Setting Clinical endocrinology and obstetrics
Key Highlights
Correction of figure legend clarifies interpretation of metabolic model coefficients and ROC curve analysis. Panel C now correctly describes changes of coefficients with lambda parameters in the metabolic model. Panel D now correctly depicts the ROC curve of the combined metabolite model enhancing differentiation of PCOS pregnancy characteristics. Guideline-Based Recommendations
Diagnosis
Utilize combined metabolite models to improve differentiation of PCOS pregnancies. Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Pregnant women diagnosed with PCOS
Metabolic profiling may aid in characterizing PCOS pregnancy features, potentially guiding clinical decisions.
Clinical Best Practices
Ensure accurate interpretation of metabolic model parameters when assessing PCOS pregnancies. Use combined metabolite ROC curve analysis to enhance diagnostic accuracy. References
